Tranzactioneaza Iovance Biotherapeutics (US.IOVA) - 4.01 USD (%) Tranzactioneaza
Indici
Descriere companie
Iovance Biotherapeutics, Inc. (http://www.iovance.com/) is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of cell therapies as cancer immunotherapy products designed to harness the power of a patient’s own immune system to eradicate cancer cells. It has developed a new, shorter manufacturing process for tumor infiltrating lymphocyte (TIL) known as Generation 2 (Gen 2), which yields a cryopreserved TIL product. The Company’s lead product candidates include lifileucel for metastatic melanoma and metastatic cervical cancer. In addition to metastatic melanoma and metastatic cervical cancer, the Company is investigating the effectiveness and safety of TIL therapy and peripheral blood lymphocyte (PBL) therapy for the treatment of squamous cell carcinoma of the head and neck, non-small cell lung cancer (NSCLC), and chronic lymphocytic leukemia (CLL).